Morningstar Investor users sign in here.

Company Profile

  • Business description

    Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

  • Contact

    400 Atlantic Street
    Suite 500
    Stamford CT 06901
    USA

    T: +1 203 406-3700

    https://www.caratherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    55

Stocks News & Analysis

video

Impact of the supermarkets code of conduct

Morningstar Director of Equity Research Johannes Faul explains the impact of the political hot water that Coles and Woolworths face. 
stocks

Four cheap wide moat ASX stocks

We follow Buffett’s adage to find great companies trading at attractive prices. 
stocks

5 top US dividend shares from the best managers

These cheap dividend stocks are popular among highly rated concentrated fund managers.

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.04 0.00 0.00%
The Star Entertainment Group Ltd SGR 0.42 0.00 0.00%
Zip Co Ltd ZIP 1.18 0.01 -0.84%
Renascor Resources Ltd RNU 0.11 0.02 26.51%
Imugene Ltd IMU 0.08 0.00 0.00%
Strickland Metals Ltd STK 0.14 0.02 12.50%
Droneshield Ltd DRO 1.12 0.18 18.52%
Telstra Group Ltd TLS 3.68 0.00 0.00%
Red 5 Ltd RED 0.43 0.01 1.18%
Evolution Mining Ltd EVN 4.16 0.29 7.49%